It was supported by data from the ASSEMBLE study, which focused on MBL infections and showed a cure rate of almost 42% versus 0% for best-available therapy. Emblaveo is the second antibiotic ...
Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...
Respiratory tract infections ... care among adult outpatients who had acute RTIs. All participants were believed — consistent with evidence-based guidelines — to require antibiotic treatment.
However, their value in the management of uncomplicated skin infections is not yet clearly defined. This literature review discusses various topical antibiotic treatment options for uncomplicated ...
Commissions do not affect our editors' opinions or evaluations. Young adults have evolving credit card needs. Many have shorter or non-existent credit histories and, for some, a life that revolves ...
Basilea Pharmaceutica may finally be able to bring its antibiotic ceftobiprole ... objectives in the ERADICATE study in adults with bacterial bloodstream infections caused by Staphylococcus ...